# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-018843
Filing Date
2022-05-12
Accepted
2022-05-12 16:26:04
Documents
3
Period of Report
2022-06-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20002080x2_def14a.htm | DEF 14A | 255005
2 |  | ny20002080x2-pc_1.jpg | GRAPHIC | 702699
3 |  | ny20002080x2-pc_2.jpg | GRAPHIC | 770555
| Complete submission text file | 0001140361-22-018843.txt |  | 2284693

Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 22918233
SIC: 2834 Pharmaceutical Preparations